Analysts: Skechers’s Margins Are Healthy and 3 More Research Notes to Check Out
Skechers (NYSE:SKX): Sterne Agee believes that most of Skechers’s brands are performing well, while Skechers’s margins should be healthy. It keeps a $36 price target and Buy rating on the stock.
Ariad Pharmaceuticals (NASDAQ:ARIA): William Blair has lowered its price target for Ariad Pharmaceuticals to $7 from $26 after the Food and Drug Administration put a partial clinical hold on Iclusig, and the firm cut its worldwide peak sales estimate for the treatment to $700 million from $2 billion. However, Blair keeps an Outperform rating on Ariad stock.
Anadarko Petroleum (NYSE:APC): Credit Suisse has added Anadarko to the U.S. 1 List due to a compelling risk/reward profile and strong franchise assets. The Anadarko shares are Outperform rated, with a $122 price target, up from $109.
Avago (NASDAQ:AVGO): Morgan Stanley believes that Avago’s valuation is attractive and that LTE adoption will drive increased dollar content in phones. The firm believes Avago is well-positioned for a rebound in communications spending and thinks that communications growth could exceed wireless in 2014. The shares are Overweight rated, with a $47 price target.